Incannex Healthcare Limited
IXHL · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | -100% | -82.2% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | 100% | 100% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | -46,643.3% | -7,268.9% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | -49,118.4% | -7,324.3% |
| EPS Diluted | -1.03 | -0.2 | -0.33 | -0.29 |
| % Growth | -415% | 39.4% | -13.8% | – |
| Operating Cash Flow | -$0 | – | -$0 | – |
| Capital Expenditures | $0 | – | -$0 | – |
| Free Cash Flow | -$0 | – | -$0 | – |